Blake Anson, Cellular Dynamics International
Claudia Bardouille, F.Hoffmann-La Roche Ltd
Tiziana Benicchi, Siena Biotech S.p.A.
Imre Berger, European Molecular Biology Laboratory (EMBL)
Cristian Bologa, University of New Mexico School of Medicine
Pascale Bouille, Vectalys
Michael Bouvier, University of Montréal
Milton Brown, Georgetown University Medical Center
Neil Burford, Bristol-Myer Squibb
Daniele Carettoni, Axxam
Darren Cawkill, Pfizer R&D
Xiaodong Cheng, Emory University
David Clapham, HHMI/Children's Hospital Boston
Charles Cohen, Xenon Pharmaceuticals
Tony Coyle, MedImmune, Inc.
Melissa Crisp, The Scripps Research Institute Florida
Tobin Dickerson, The Scripps Research Institute
Hakim Djaballah, Memorial Sloan-Kettering Cancer Center
Jilly Evans, Amira Pharmaceuticals
Christopher M. Fanger, Hydra Biosciences
Yuriy Fedorov, Thermo Fisher Scientific
Jutta Fritz, KINAXO Biotechnologies GmbH
Susan George, University of Toronto
Andrew Golden, Novartis
Vincent Groppi, Essen Instruments
Carsten Grötzinger, Charite - University Medicine Berlin
Stephan Haggarty, Harvard Medical School
Alexander Hillisch, Bayer Schering Pharma AG
Peter Hodder, The Scripps Research Institute, Scrips Florida
Michael Howell, Cancer Research UK
James Inglese, NIH Chemical Genomics Center
David Israel, GlaxoSmithKline
Manfred Jung, University of Freiburg
Nicol Keith, University of Glasgow
Scott Kennedy, RainDance Technologies
William Kisaalita, University of Georgia
Alan Kozikowski, University of Illinois at Chicago
Eberhard Krausz, Tibotec BVBA
William LaMarr, BIOCIUS Life Sciences, Inc.
Bruce Levy, Brigham and Women's Hospital
Chuck Li, Amgen, Inc.
Yu-Wen Li, Bristol-Myers Squibb
Chiara Liberati, Axxam SpA
Christopher Lord, The Institute of Cancer Research
|
|
Steve Ludbrook, GlaxoSmithKline R&D
Dan Luo, Cornell University
Ricardo Macarron, GlaxoSmithKline
Harald Mauser, F. Hoffmann-La Roche Ltd.
Owen McManus, McManus Consulting
Tadashi Mori, Mitsubishi Tanabe Pharma Corporation and Tohoku University
Jason C. O'Connor,University of Illinois at Urbana-Champaign
Jean-Yves Ortholand, EDELRIS
Keiko Ozato, National Institues of Health
Amy Quinn, NIH Chemical Genomics Center, NHGRI, National Institutes of Health
Stephen Rees, GlaxoSmithKline
Juergen Reinhardt, Novartis Institute for Biomedical Research
Bruce Richardson, University of Michigan
Hugh Rosen, The Scripps Research Institute
Jonathan Rosenberg, IMGENEX Corporation
Nathan Ross, Broad Institute
Adriano Rossi, University of Edinburgh
Gregory Roth, Burnham Institute for Medical Research at Lake Nona
Ulrich Rothbauer, Biocenter of the Ludwig-Maximilians University Munich (LMU)
Rachel Russell, Pfizer R&D
Stephan Schann, Domain Therapeutics
Liang Schweizer , Bristol-Myers Squibb
Vincent Setola, NIMH Psychoactive Drug Screening Program
Kathleen Seyb, Brigham and Women's Hospital
Peter Simpson, AstraZeneca Cancer Bioscience
Babu Tekwani, National Center for Natural Products Research
Nicola Tolliday, Broad Institute
Joseph Toth, Adnexus, a BMS R&D Company
Philip Vickers, Resolvyx Pharmaceuticals
George P. Vlasuk, Sirtris, a GSK Company
Moira Whyte, University Of Sheffield
Tim Wigle, UNC Center for Integrative Chemical Biology & Drug Discovery
Dirk Winkler, Evotec AG
Edgar Wood, GlaxoSmithKline
Paul Workman, Cancer Research UK Centre for Cancer Therapeutics The Institute of Cancer Research
Yang Wu, University of New Mexico
Biao Xi, ACEA Biosciences, Inc.
Han Xu, Amgen Inc
Wei Zhang, GlaxoSmithKline R&D China
|
